Clinical Trials Browser

Phase EARLY_PHASE1 × OTHER_GOV × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Clear all

NCT06277011 2024-02-26

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma